Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis

J Thorac Cardiovasc Surg. 2023 Dec;166(6):e535-e550. doi: 10.1016/j.jtcvs.2023.08.017. Epub 2023 Aug 20.

Abstract

Objectives: Sodium-glucose cotransporter-2 inhibitor, canagliflozin, improves myocardial perfusion to ischemic territory without accompanying changes in vascular density. We aimed to (1) characterize effects on angiogenic pathways, (2) use multiomics to identify gene expression and metabolite profiles relevant to regulation of myocardial blood flow, and (3) investigate drug effect on coronary microvascular reactivity.

Methods: A nondiabetic swine model of chronic myocardial ischemia and nondiabetic rat model were used to study functional and molecular effects of canagliflozin on myocardium and in vitro microvascular reactivity.

Results: Canagliflozin resulted in increased coronary microvascular vasodilation and decreased vasoconstriction (P < .05) without changes in microvascular density (P > .3). Expression of the angiogenic modulator, endostatin, increased (P = .008), along with its precursor, collagen 18 (P < .001), and factors that increase its production, including cathepsin L (P = .004). Endostatin and collagen 18 levels trended toward an inverse correlation with blood flow to ischemic territory at rest. Proangiogenic fibroblast growth factor receptor was increased (P = .03) and matrix metalloproteinase-9 was decreased (P < .001) with canagliflozin treatment. Proangiogenic vascular endothelial growth factor A (P = .13), Tie-2 (P = .10), and Ras (P = .18) were not significantly altered. Gene expression related to the cardiac renin-angiotensin system was significantly decreased.

Conclusions: In chronic myocardial ischemia, canagliflozin increased absolute blood flow to the myocardium without robustly increasing vascular density or proangiogenic signaling. Canagliflozin resulted in altered coronary microvascular reactivity to favor vasodilation, likely through direct effect on vascular smooth muscle. Downregulation of cardiac renin-angiotensin system demonstrated local regulation of perfusion. VIDEO ABSTRACT.

Keywords: angiogenesis; chronic myocardial ischemia; microvascular reactivity; myocardial perfusion.

Publication types

  • Video-Audio Media
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Canagliflozin / metabolism
  • Canagliflozin / pharmacology
  • Canagliflozin / therapeutic use
  • Endostatins / metabolism
  • Endostatins / pharmacology
  • Endostatins / therapeutic use
  • Myocardial Ischemia*
  • Myocardium / metabolism
  • Rats
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Swine
  • Vascular Endothelial Growth Factor A / pharmacology
  • Vasodilation

Substances

  • Canagliflozin
  • Vascular Endothelial Growth Factor A
  • Sodium-Glucose Transporter 2 Inhibitors
  • Endostatins